• Skip to main content
  • Skip to primary sidebar
Transfusion News
  • About Us
  • Topics
    • Adverse Events (non-infectious)
    • Blood Donation
    • Cell Therapy
    • Coagulation & Plasma Transfusion
    • Platelet Transfusion
    • Policy and Guidelines
    • Quality Control and Regulatory
    • RBC Transfusion
    • Serology/Genotyping
    • Special Transfusion Situations
    • Transfusion Transmitted Infections
  • Continuing Education
  • Archives
  • Podcasts
  • Question of the Day
  • Search
  • Subscribe to Email Alerts
  • Follow us on
  • Search
  • Subscribe to Email Alerts

Costs are High for Administrating Blood Transfusions

April 11, 2018

A recent micro-costing study in the United Kingdom suggests administration costs are high for blood transfusions. Researchers collected detailed data on key inputs for blood transfusions for all laboratory supplies and staff time, including all laboratory personal and nurses at two large hospitals in Oxford and Reading.  The cost of wasted blood products was also examined in the study.  The mean costs per unit for administering transfusions to a patient on a regular day-unit ward were $71 for RBCs, $84 for platelets, $55 for fresh-frozen plasma, and $72 for cryoprecipitate.  For each blood component, the administration costs for the first unit transfused exceeded administration costs for subsequent units for the same patient.  Further costing studies are needed from other hospitals and countries to best determine how to efficiently use and administer blood products.

References:

  1. Stokes EA, Wordsworth S, Staves J, Mundy N, Skelly J, Radford K, and SJ Stanworth. Accurate costs for blood transfusion: a microcosting of administering blood products in the United Kingdom National Health Service. Transfusion 2018
  2. Cataife G and MB Pagano. How much does a blood transfusion cost? Transfusion 2018

Filed Under

  • Coagulation & Plasma Transfusion
  • News
  • Platelet Transfusion
  • RBC Transfusion

Recommended

  • New Assessment Criteria to Diagnose and Manage Delayed Hemolytic Transfusion Reactions in Sickle Cell Patients

  • Mitapivat Trial Results in Adults with Pyruvate Kinase Deficiency Requiring Transfusions

  • Serological Screening of Blood Donations Suggests SARS-CoV-2 May Have Been Introduced in the US before January 2020

Show Comments

Comments on this article are closed.

Get the latest news. Subscribe to our mailing list. Sign Up

Primary Sidebar

Latest News

  • Multifaceted Threats to the Blood Supply from Climate Change

  • Distinct Roles for Differently Aged Platelets

  • Anemia Treatment Bundle Improves Hemoglobin Recovery after Critical Illness

  • Prothrombin Complex Concentrate Is Safe and Effective for Cardiac Surgery Patients with Coagulopathic Bleeding

    Question of the Day

    Copyright © 2025 John Wiley & Sons, Inc. All Rights Reserved.
    Privacy Policy

    Association for the Advancement of Blood and Biotherapies Wiley